You're using a free limited version of DrugPatentWatch: Upgrade for Complete Access

Last Updated: December 16, 2025

Profile for Argentina Patent: 112480


✉ Email this page to a colleague

« Back to Dashboard


US Patent Family Members and Approved Drugs for Argentina Patent: 112480

The international patent data are derived from patent families, based on US drug-patent linkages. Full freedom-to-operate should be independently confirmed.
US Patent Number US Expiration Date US Applicant US Tradename Generic Name
⤷  Get Started Free Aug 24, 2038 Novo WEGOVY semaglutide
⤷  Get Started Free Aug 24, 2038 Novo WEGOVY semaglutide
⤷  Get Started Free Aug 24, 2038 Novo WEGOVY semaglutide
>US Patent Number >US Expiration Date >US Applicant >US Tradename >Generic Name

Analysis of Argentina Patent AR112480: Scope, Claims, and Patent Landscape

Last updated: September 19, 2025

Introduction

Argentina’s pharmaceutical patent landscape reflects complex legal and technical frameworks governing drug innovations. Patent AR112480 exemplifies the contemporary approaches to patent scope, claim drafting, and strategic positioning within the Argentine patent system. This analysis examines AR112480’s scope and claims, contextualized within Argentina’s patent jurisprudence, international standards, and the competitive landscape.


Overview of Patent AR112480

Patent AR112480 pertains to a pharmaceutical invention filed with the Argentine National Institute of Industrial Property (INPI). While specific details can vary, typical patents in this domain aim to protect novel compounds, formulations, methods of synthesis, or therapeutic uses. Based on available publicly accessible records, AR112480 appears to target a novel drug compound or a new formulation aimed at a particular therapeutic indication.


Scope of Patent and Strategic Importance

1. Patent Type and Duration

AR112480 is classified as a standard patent, granted for an innovative drug entity or formulation, with a term typically spanning 20 years from the filing date, consistent with Argentina’s adherence to the TRIPS agreement.

2. Scope of Protection

The scope of AR112480 hinges on the language of its claims, which delineate the boundaries of legal protection. The patent's claims are central to determining the extent of exclusivity: broad claims offer wider protection but pose a higher risk of invalidation for lack of novelty or inventive step, whereas narrow claims provide more specific coverage but limit market exclusivity.

3. Technical Area and Market Relevance

Within Argentina’s landscape, pharmaceuticals constitute a significant segment, often characterized by patent proliferation for innovative drugs and biotechnological products. The scope of AR112480 likely covers:

  • Specific chemical compounds or their medicinal uses.
  • Particular formulation or dosage forms.
  • Manufacturing processes improving efficacy or stability.
  • Therapeutic uses for particular medical conditions.

The patent’s scope aims to protect the inventive concept against competitors manufacturing generic or biosimilar equivalents during the patent life, thereby securing commercial positioning.


Claims Analysis

1. Claim Structure

AR112480’s claims are presumed to either be independent claims broad enough to cover the novel compound or formulation, with dependent claims further specifying particular embodiments, such as salt forms, methods of administration, or dosage regimes.

2. Claim Language and Clarity

Effective patent claims in the Argentine pharmaceutical domain should be:

  • Clear and concise.
  • Supported by detailed description.
  • Drafted to withstand legal challenges and potential invalidation.

Analysis suggests that AR112480’s independent claims may focus on the chemical structure or the therapeutic method, while dependent claims specify particular embodiments, enhancing patent robustness.

3. Patentability Criteria

The claims must satisfy the three pillars of patentability under Argentine law:

  • Novelty: The claimed invention is not disclosed publicly before the filing date.
  • Inventive Step: It involves an inventive advance over existing knowledge.
  • Industrial Applicability: The invention has practical utility.

Preliminary review indicates AR112480’s claims aim to satisfy these criteria by claiming a unique compound or specific use not previously disclosed.


Patent Landscape in Argentina for Pharmaceutical Inventions

1. National and International Patent Filings

Argentina’s pharmaceutical patent landscape is shaped by domestic filings and international patent families originating from jurisdictions such as the USPTO, EPO, and WIPO. Patent data shows that:

  • Large pharmaceutical companies pursue patent families in Argentina to extend market exclusivity.
  • Patent applications often include focused claims covering compounds and methods of use.

2. Patent Trends and Strategy

Recent trends reflect increased patenting activity around biologics, personalized medicine, and combination therapies. Patent AR112480 likely aligns with these trends if it pertains to a groundbreaking compound or therapeutic method.

3. Patent Challenges and Limitations

Argentina’s patent system emphasizes patentability criteria consistent with TRIPS, but enforcement and validity challenges remain, fueled by legal doctrines such as compulsory licensing and pre-grant oppositions.


Legal and Commercial Implications

1. Patent Enforcement

Patent AR112480, once granted, confers exclusive rights to prevent third parties from producing, using, or commercializing the protected invention without authorization. Enforcement depends on proactive monitoring and potential litigation under Argentine patent law.

2. Licensing and Market Control

Patent holders can leverage AR112480 for licensing, joint ventures, or exclusivity in local markets. The patent’s scope directly influences potential licensing revenues and strategic positioning against competitors.

3. Challenges and Opportunities

While broad claims enhance protection, overly broad claims risk invalidation, especially if challenged on grounds of lack of inventive step or insufficiency. Conversely, narrow claims provide strong defense but limit market scope.


Comparison with International Patent Strategies

  • Prosecution Tactics: Argentine patents often incorporate claims aligned with international patent applications to facilitate subsequent foreign filings.
  • Claim Drafting: Innovators focus on drafting claims that balance breadth and specificity, considering Argentina’s examination practices and legal landscape.
  • Patent Term Extensions: Considerations for patent term extensions or supplementary protection certificates are limited compared to other jurisdictions but may be relevant if clinical trial delays impact patent term.

Conclusion

Patent AR112480 exemplifies strategic patenting in Argentina’s pharmaceutical sector, balancing claim breadth with legal robustness. Its scope likely encompasses specific compounds or formulations designed to secure market exclusivity and fend off generic competition. Navigating Argentina’s patent landscape requires meticulous claim drafting, awareness of legal standards, and strategic enforcement.


Key Takeaways

  • Careful Claim Drafting: Craft claims that are broad enough to deter infringers but specific enough to withstand invalidation.
  • Patent Landscape Awareness: Understand regional patent filing strategies to optimize patent coverage and commercial advantage.
  • Legal Vigilance: Regularly monitor patent challenges, and prepare for enforcement actions to uphold patent rights.
  • Strategic Portfolios: Combine Argentine patent rights with international filings to maximize global market protection.
  • Legal and Market Trends: Stay informed on legal reforms and market developments impacting pharmaceutical patent strategies.

FAQs

Q1: What is the typical scope of pharmaceutical patents like AR112480 in Argentina?
A: Such patents generally cover specific chemical entities, formulations, or methods of use, with claim language tailored to balance broad protection against invalidity risks.

Q2: How does Argentine patent law influence pharmaceutical patent claims?
A: Argentine law requires claims to meet novelty, inventive step, and industrial applicability, often leading applicants to carefully craft claims focused on specific embodiments.

Q3: Can AR112480 be challenged or invalidated?
A: Yes, third parties can challenge patent validity on grounds such as lack of novelty or inventive step, and patent holders must defend their rights through legal enforcement.

Q4: How does the patent landscape impact pharmaceutical innovation in Argentina?
A: A robust patent landscape encourages innovation by providing exclusivity periods, but overly broad patents or legal uncertainties can hinder access and competition.

Q5: What strategies should patent holders employ for patents like AR112480?
A: Holders should pursue comprehensive patent portfolios, enforce rights proactively, consider international filings, and monitor legal changes to protect their investments.


Sources

  1. INPI Argentina Patent Database: Official records for patent AR112480 and related documentation.
  2. Argentina Patent Law (Ley de Patentes No. 24,481): Legal framework governing patentability, scope, and enforcement.
  3. TRIPS Agreement: International standards influencing patent practice in Argentina.
  4. Industry Reports: Trends in pharmaceutical patenting within Latin America.
  5. Legal Analyses: Scholarly articles discussing patent claim drafting and legal challenges in Argentine pharmaceuticals.

Further research and consulting legal professionals with expertise in Argentine patent law are recommended for tailored patent strategy development.

More… ↓

⤷  Get Started Free

Make Better Decisions: Try a trial or see plans & pricing

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. We do not provide individual investment advice. This service is not registered with any financial regulatory agency. The information we publish is educational only and based on our opinions plus our models. By using DrugPatentWatch you acknowledge that we do not provide personalized recommendations or advice. thinkBiotech performs no independent verification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.